Pages

Wednesday, August 29, 2012

Waiting To Treat CMV May Benefit Kidney Transplant Patients.

MedPage Today Share to FacebookShare to Twitter (8/27, Fiore) reports, "Waiting to treat cytomegalovirus (CMV) in kidney transplant patients may deliver better long-term outcomes than blanket preventive drugs," according to a study Share to FacebookShare to Twitter published online in the Journal of the American Society of Nephrology. Investigators found, "in a small randomized trial," that "organ graft survival was significantly worse for those having CMV prophylaxis (P=0.044) compared with those who received therapy for CMV viremia, and more of these patients had interstitial fibrosis and tubular atrophy though the difference wasn't significant (38% versus 19%, P=0.22)."

No comments:

Post a Comment